Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $358,549 | 142 | 68.3% |
| Travel and Lodging | $132,834 | 400 | 25.3% |
| Consulting Fee | $18,114 | 6 | 3.5% |
| Food and Beverage | $15,116 | 391 | 2.9% |
| Education | $109.53 | 18 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $417,898 | 721 | $0 (2024) |
| Celgene Corporation | $49,698 | 86 | $0 (2019) |
| Amgen Inc. | $41,471 | 61 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $14,431 | 24 | $0 (2023) |
| UCB, Inc. | $360.14 | 19 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $128.70 | 8 | $0 (2023) |
| PFIZER INC. | $121.99 | 4 | $0 (2024) |
| Lilly USA, LLC | $120.80 | 7 | $0 (2024) |
| Janssen Biotech, Inc. | $117.21 | 9 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $72.43 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $54,623 | 99 | ABBVIE INC. ($54,174) |
| 2023 | $51,020 | 97 | ABBVIE INC. ($35,326) |
| 2022 | $72,635 | 127 | ABBVIE INC. ($55,194) |
| 2021 | $39,451 | 85 | AbbVie Inc. ($36,108) |
| 2020 | $31,791 | 58 | AbbVie Inc. ($24,577) |
| 2019 | $132,505 | 227 | AbbVie, Inc. ($104,006) |
| 2018 | $128,337 | 232 | AbbVie, Inc. ($108,513) |
| 2017 | $14,359 | 32 | Celgene Corporation ($14,332) |
All Payment Transactions
957 individual payment records from CMS Open Payments — Page 1 of 39
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $175.54 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $174.20 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $156.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $129.60 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $60.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $55.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,150.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: DERMATOLOGY | ||||||
| 11/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $292.43 | General |
| Category: IMMUNOLOGY | ||||||
| 11/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: IMMUNOLOGY | ||||||
| 11/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Immunology | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $816.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/01/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $510.78 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $32.96 | General |
| Category: IMMUNOLOGY | ||||||
| 10/29/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $123.88 | General |
| Category: Immunology | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $724.80 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $701.90 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $415.36 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $11.06 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | Lilly USA, LLC | TALTZ (Drug), OLUMIANT, EBGLYSS | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Immunology | ||||||
| 09/25/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: DERMATOLOGY | ||||||
| 09/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,748 | 3,481 | $292,098 | $88,915 |
| 2022 | 11 | 1,992 | 4,226 | $321,972 | $102,193 |
| 2021 | 13 | 2,131 | 4,428 | $335,075 | $109,523 |
| 2020 | 14 | 2,093 | 4,235 | $333,183 | $102,774 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 498 | 735 | $91,875 | $27,719 | 30.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 226 | 356 | $60,520 | $19,139 | 31.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 378 | 491 | $51,555 | $15,886 | 30.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 366 | 1,561 | $20,293 | $6,354 | 31.3% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 39 | 56 | $17,080 | $5,592 | 32.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 62 | 64 | $14,720 | $4,900 | 33.3% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 78 | 116 | $15,080 | $3,034 | 20.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $6,560 | $2,070 | 31.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 12 | 12 | $5,820 | $2,051 | 35.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 46 | 46 | $6,440 | $1,348 | 20.9% |
| 69100 | Biopsy of ear | Office | 2023 | 11 | 12 | $2,155 | $822.59 | 38.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 563 | 837 | $104,675 | $31,404 | 30.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 234 | 342 | $52,634 | $18,800 | 35.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 414 | 559 | $54,648 | $17,621 | 32.2% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 441 | 2,076 | $25,870 | $8,588 | 33.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 46 | 75 | $21,900 | $8,253 | 37.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 63 | 69 | $15,540 | $5,058 | 32.5% |
| 11642 | Removal of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2022 | 19 | 21 | $10,115 | $3,817 | 37.7% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2022 | 92 | 127 | $16,510 | $3,278 | 19.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 44 | 44 | $8,810 | $2,566 | 29.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 61 | 61 | $8,540 | $2,112 | 24.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 15 | 15 | $2,730 | $695.73 | 25.5% |
| 17000 | Destruction of skin growth | Office | 2021 | 604 | 868 | $117,180 | $32,395 | 27.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 419 | 543 | $45,612 | $18,024 | 39.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 214 | 294 | $39,822 | $15,825 | 39.7% |
About Alan Olmstead
Alan Olmstead is a Specialist healthcare provider based in Twin Falls, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306936794.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Alan Olmstead has received a total of $524,722 in payments from pharmaceutical and medical device companies, with $54,623 received in 2024. These payments were reported across 957 transactions from 18 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($358,549).
As a Medicare-enrolled provider, Olmstead has provided services to 7,964 Medicare beneficiaries, totaling 16,370 services with total Medicare billing of $403,406. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Other Specialties Dermatology
- Location Twin Falls, ID
- Active Since 10/13/2006
- Last Updated 12/05/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306936794
Products in Payments
- Humira (Biological) $133,824
- RINVOQ (Biological) $101,412
- Otezla (Drug) $91,015
- SKYRIZI (Biological) $90,446
- Skyrizi (Biological) $54,515
- COSENTYX (Biological) $14,153
- HUMIRA (Biological) $12,319
- COSENTYX (Drug) $236.31
- Cimzia (Drug) $182.65
- Bimzelx (Biological) $177.49
- TREMFYA (Drug) $134.86
- TALTZ (Drug) $120.80
- CIBINQO (Drug) $94.16
- ILUMYA (Biological) $89.66
- VTAMA (Drug) $71.09
- ADBRY (Biological) $56.11
- Tremfya (Drug) $54.78
- HADLIMA (Drug) $42.95
- Ilumya (Biological) $39.04
- OPZELURA (Drug) $37.92
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Twin Falls
Clinton Dille, M.d, M.D
Specialist — Payments: $2,316
Rod Kack, Md, MD
Specialist — Payments: $1,391
Marilyn Righetti, Md, MD
Specialist — Payments: $77.31
Dr. Miles Humphrey, M.d, M.D
Specialist
Brad Hobbs, M.d, M.D
Specialist
Stanley Mogelson, M.d, M.D
Specialist